is widespread in tumor cells, even clinical studies revealed that the concentration of H 2 O 2 in cancerous tissues is many times higher (ranging from 100 × 10 −6 to 1 × 10 −3 m) compared to that in normal tissues (35 × 10 −6 m). [15,16] The differentiated ROS level in different regions inspires the development of ROS-responsive micelles for targeted drug delivery. [17][18][19] Motifs such as thioether, thioketal, ferrocene, tellurium, selenium, and boronic ester are introduced to the structures of the polymers to endow the self-assembled micelles with ROS-responsiveness. [20][21][22][23][24] However, current designs always allow the micelles to exhibit responsive drug delivery at relatively high concentrations of ROS, which is the main obstacle to limit their further uses. Therefore, it is highly pressing to improve the sensitivity of the ROS-responsive polymeric nanocarriers.Zhu and co-workers reported a cinnamaldehyde-encapsulated nanomicellar system based on H 2 O 2 -responsive hyperbranched polyglycerols with thioether-linked anticancer drug of 7-ethyl-10-hydroxy-camptothecin (SN38). [25] The in vitro study proposed that the preferentially released cinnamaldehyde (CA) could effectively induce intracellular ROS generation and accelerate the micellar degradation to release SN38 for an enhanced cancer therapy. Ge and co-workers fabricated a novel ROS-responsive polyprodrug polymersome loaded with ultrasmall iron oxide nanoparticles and glucose oxidase. The tumor acidity-activable Fenton reaction can efficiently produce ·OH to trigger camptothecin (CPT) release for high-efficient cooperative cancer therapy. [26] Such strategies involve locally catalyzingtriggered chemical reactions to generate abundant and special products only inside tumor tissues and therefore provide a highly efficient tumor-specific theranostic effects. Cancer tissues are usually featured with mild acidic conditions and high ROS levels due to the fast metabolism-induced overproduction of metabolic products. [17][18][19][20][21][22][23][24][25][26][27][28][29] In addition, the concentration of Cu(II) ions in cancer cells is 2-3 times higher than that within normal cells (0.98 µg mL −1 ), while the concentrations of Zn(II), Fe(III), and Se(II) are significantly lower in cancer tissues. [30] It should be noted that a Fenton-like reaction may occur for the polyphenols and Cu(II) complexed system to quickly generate a variety of reactive oxygen species. [31] Therefore, cancer tissues are more subject to electron transfer between Cu(II) ions and polyphenols to generate ROS. Such Cu-complexed Fenton-like reaction can also effectively induce the tumor-specific therapy Compared to normal cells, there is a relatively high level of reactive oxygen species (ROS) in tumor cells caused by defecting ROS scavenging systems. To this issue, developing ROS-responsive nanocarriers has been a promising way to cancer therapy. However, it is always difficult for a certain ROSresponsive nanocarrier to be perfectly triggered due to the complexity of cancerous tissue...